Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2021

Jan 26, 2021

31873_dirs_2021-01-26_74af49ac-467b-4f96-964b-4abdf8643e9b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-01-22

Reporting Person: Banyai William (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-22 Common Stock F 210 $190.64 Disposed 476036 Direct
2021-01-25 Common Stock S 1500 $185.4507 Disposed 474536 Direct
2021-01-25 Common Stock S 1000 $186.3850 Disposed 473536 Direct
2021-01-25 Common Stock S 1820 $187.5562 Disposed 471716 Direct
2021-01-25 Common Stock S 1700 $188.7206 Disposed 470016 Direct
2021-01-25 Common Stock S 606 $189.6592 Disposed 469410 Direct
2021-01-25 Common Stock S 100 $191.81 Disposed 469310 Direct
2021-01-25 Common Stock S 369 $193.00 Disposed 468941 Direct
2021-01-25 Common Stock S 900 $194.9283 Disposed 468041 Direct
2021-01-25 Common Stock S 800 $196.1006 Disposed 467241 Direct
2021-01-25 Common Stock S 2300 $197.0813 Disposed 464941 Direct
2021-01-25 Common Stock S 2001 $198.3802 Disposed 462940 Direct
2021-01-25 Common Stock S 803 $199.2378 Disposed 462137 Direct
2021-01-25 Common Stock S 200 $199.9850 Disposed 461937 Direct

Footnotes

F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).

F2: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $184.79 to $185.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $185.87 to $186.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $187.14 to $187.98 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $188.38 to $189.20 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $189.64 to $189.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F8: Represents the weighted average sales price per share. The shares sold at prices ranging from $194.51 to $195.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F9: Represents the weighted average sales price per share. The shares sold at prices ranging from $195.69 to $196.59 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F10: Represents the weighted average sales price per share. The shares sold at prices ranging from $196.80 to $197.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F11: Represents the weighted average sales price per share. The shares sold at prices ranging from $197.88 to $198.88 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F12: Represents the weighted average sales price per share. The shares sold at prices ranging from $198.90 to $199.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F13: Represents the weighted average sales price per share. The shares sold at prices ranging from $199.96 to $200.01 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.